LLY Total Assets
Everything the company owns at each quarter end — the balance-sheet total, not a flow.
Total Assets
Latest: $142.28B (2026Q2)
| Period | Value |
|---|---|
| 2024Q1 | $63.94B |
| 2024Q2 | $71.87B |
| 2024Q3 | $75.61B |
| 2024Q4 | $78.72B |
| 2025Q1 | $89.39B |
| 2025Q2 | $100.92B |
| 2025Q3 | $114.94B |
| 2025Q4 | $112.48B |
| 2026Q1 | $116.58B |
| 2026Q2 | $142.28B |
Other LLY Charts
More quarter-by-quarter fundamentals for Eli Lilly and Company
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Total Assets
Total Assets
Total Assets
Latest Total Assets: $142.28B (2026Q2); +41.0% YoY.
Across the 10 quarters from 2024Q1 to 2026Q2, Total Assets ranged from $63.94B in 2024Q1 to $142.28B in 2026Q2.